Pharma


  • Opioids, pills, syringe
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip
    Q&A

    As the opioid crisis seethes, a long-lasting treatment could offer new ammunition

    Launched this month, Brixadi from Braeburn gives patients a new tool to overcome addiction.

    By Sept. 21, 2023
  • Ivermectin boxes and a mask against a red background
    Image attribution tooltip
    Jos Everts via Getty Images via Getty Images
    Image attribution tooltip

    What happened to ivermectin?

    The saga of the anti-parasitic drug continues.

    By Alexandra Pecci • Sept. 20, 2023
  • test tube gene Explore the Trendline
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Cell and gene therapies

    How the industry is overcoming hurdles in cell and gene therapy space and pushing for the next generation of treatments.

    By PharmaVoice staff
  • Congressman Garcia gestures to a cardboard meme of two identical Spiderman characters pointing at one another.
    Image attribution tooltip
    Rebecca Pifer/PharmaVoice
    Image attribution tooltip

    PBMs, PhRMA trade blame over drug costs in House hearing

    Pharmacy benefit manager lobby PCMA and drugmaker lobby PhRMA pointed fingers over problems in the prescription supply chain during the House committee's second PBM hearing on Tuesday.

    By Rebecca Pifer • Sept. 19, 2023
  • PharmaVoice 100 header
    Image attribution tooltip
    Illustration: Deena So Oteh for Industry Dive/PharmaVoice
    Image attribution tooltip

    The 2023 PharmaVoice 100

    This year’s honorees are influential and devoted leaders lifting the pillars of the industry to new heights.

    By Sept. 19, 2023
  • Horseshoe crab
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip

    Endangered horseshoe crabs could lead the charge in pharma’s animal-free future

    An effort to spare the species from blood collection is one of many ways the industry is turning away from animals for R&D.

    By Kelly Bilodeau • Sept. 18, 2023
  • Pharma five-year plan
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip

    Moderna’s bold five-year plan reflects Big Pharma tradition of ‘Will they deliver?’

    Forecasts from the biggest pharma companies follow a pattern of thinking big and manifesting the desired outcome.

    By Sept. 15, 2023
  • Actor Ice T puts hands up in the air.
    Image attribution tooltip
    Courtesy of Sanofi
    Image attribution tooltip

    O.G. Ice-T teams up with Sanofi in horror-themed flu vax ad

    The French pharma’s latest vaccine campaign aims to raise awareness about the flu’s complications for marginalized groups. 

    By Sept. 14, 2023
  • leaders hands
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Catching up with 2022 PharmaVoice 100 honorees

    Tapping into our growing community for expertise and inspiration.

    By Sept. 13, 2023
  • pharmacist scanning prescription
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    A healthcare paradox: Drugs are too expensive but ‘easy’ to afford, Americans say

    A new poll shows that Americans generally support several key IRA provisions, including Medicare price negotiations.

    By Alexandra Pecci • Sept. 12, 2023
  • Blue and red pill capsules scattered on a table
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    In advocates’ ongoing push for superbug funding, ‘$6 billion is nothing’

    The PASTEUR Act is likely heading for another legislative blow, but advocates say they see a future for the mechanism to fund the battle against antimicrobial resistance.

    By Sept. 8, 2023
  • Armon horiztonal
    Image attribution tooltip
    Permission granted by Armon Sharei
    Image attribution tooltip
    Profile

    ‘Not all rainbows and unicorns’ — a former CEO dishes on his rocky biotech ride

    Armon Sharei took his startup SQZ from a graduate project at MIT to a Big Pharma partnership worth $1B+. Despite the company’s stumbles, Sharei’s enthusiasm for biotech’s future remains.

    By Sept. 7, 2023
  • Business person standing in front of window looking at city view.
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Pharma faces a slew of leadership shakeups

    Biogen, Sanofi, Bristol Myers Squibb and more have all recently announced major executive changes.

    By Sept. 7, 2023
  • Professional headshot of Murray McKinnon
    Image attribution tooltip
    Courtesy of Empress Therapeutics
    Image attribution tooltip
    Profile

    Why this scientist left Janssen to help ‘revolutionize’ small molecule drug discovery

    Murray McKinnon, CSO of Empress Therapeutics, believes its drug discovery platform holds the key to treating and detecting many diseases.

    By Alexandra Pecci • Sept. 6, 2023
  • A Roche logo is seen on the side of a building.
    Image attribution tooltip
    Courtesy of Roche
    Image attribution tooltip

    Hope sputters for emerging anti-TIGIT drug class

    Leaked data for Roche’s immunotherapy appeared positive, but some experts aren’t convinced it’ll make an impact for cancer patients.

    By Kelly Bilodeau • Sept. 5, 2023
  • roz Brewer
    Image attribution tooltip

    Permission granted by Roz Brewer

    Image attribution tooltip

    Roz Brewer announces sudden departure as CEO of Walgreens

    The exec who set out to overhaul the long-time pharmacy giant offered few details on why she's stepping down.

    By Sept. 1, 2023
  • A prescription bottle with white pills and a wooden gavel sit atop a $100 bill showing Benjamin Franklin's face.
    Image attribution tooltip
    Bill Oxford via Getty Images
    Image attribution tooltip

    Lawmakers are already gunning for more dramatic drug pricing reforms

    Medicare just announced its first-ever drug price negotiations and legislators are quickly pushing to broaden the program.

    By Aug. 31, 2023
  • CSL Seqirus influenza vaccine being prepared in the lab.
    Image attribution tooltip
    Permission granted by CSL Seqirus
    Image attribution tooltip

    Finding the right flu vaccine is hard. Getting people to take it is harder.

    Experts have determined the strains of this year’s flu season — now the question is whether people are too fatigued by the pandemic to be immunized.

    By Aug. 30, 2023
  • Joe Biden stands at a podium flanked on either sides by screens that read: "lowering costs for American families."
    Image attribution tooltip
    Win McNamee / Staff via Getty Images
    Image attribution tooltip

    Medicare named the first 10 drugs up for negotiation. Now what?

    The list of blockbuster cardiovascular, diabetes and cancer drugs gives the industry a window into how regulators are approaching price negotiations.

    By Aug. 30, 2023
  • test tube salute
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    5 of the best places to work in pharma, according to employees

    Work-life balance is one major common denominator among the top-ranked pharma employers on Glassdoor.

    By Alexandra Pecci • Aug. 29, 2023
  • A white pill bottle, pills and a measuring tap sit on a dish on top of a yellow table
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Are weight loss drugs a win for the global economy?

    As Novo Nordisk’s drug Wegovy sways Denmark’s economy, we're examining wider implications for the weight loss market. 

    By Aug. 28, 2023
  • head brain pill
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Why pharma isn’t done tackling migraines

    In the high-growth but competitive field of migraine treatments, CGRP drugs have changed the game — but the search is still on for more options. 

    By Kelly Bilodeau • Aug. 28, 2023
  • Pills of varying colors lay against a blue background
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Drug shortages: The ‘fundamental problem’ that has pharma’s top regulator ‘fired up’

    FDA Commissioner Robert Califf suggested larger reforms are needed to bolster the generic drug industry and prevent future medication shortages. 

    By Aug. 25, 2023
  • COVID shot
    Image attribution tooltip
    Joe Raedle / Staff via Getty Images
    Image attribution tooltip

    ‘Eris’ and other new COVID strains accelerate vaccine push from Pfizer, Moderna, Novavax

    New variants drive a need for another round of shots, and biopharma companies are stepping up to the plate.

    By Aug. 24, 2023
  • Shubh Goel, head of immuno-oncology, gastrointestinal tumors franchise, AstraZeneca
    Image attribution tooltip
    Permission granted by AstraZeneca
    Image attribution tooltip

    How an AstraZeneca exec is leading the charge in the next immuno-oncology era

    The pharma giant’s head of immuno-oncology is now charging toward the next step in the cancer fight with long-term survival and precision.

    By Aug. 17, 2023
  • Rep. Adam Smith sits at a podium with blue curtain behind.
    Image attribution tooltip
    Chip Somodevilla / Staff via Getty Images
    Image attribution tooltip
    Q&A

    A leading Democrat reveals how his mental health struggles shape his policy approach

    Seattle Congressman Adam Smith's journey with anxiety and chronic health has influenced his perspective on healthcare and pharmaceutical policy.

    By Aug. 17, 2023